Patents by Inventor Kerstin Schütze

Kerstin Schütze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIGEN-BINDING POLYPEPTIDES DIRECTED AGAINST CD38
    Publication number: 20210332148
    Abstract: The invention relates to polypeptides specifically binding to CD38 and are therefore suitable for the diagnosis and for the therapeutic and prophylactic treatment of diseases which are characterized by increased CD38 expression. Conjugates and pharmaceutical compositions comprising the polypeptides are disclosed as well. In addition, the invention relates to the use of such polypeptides in methods for the detection of CD38 and/or CD38-expressing cells in a biological sample. A process for the purification and concentration of CD38 and/or CD38-expressing cells in which the antigen-binding polypeptides are used are also described.
    Type: Application
    Filed: December 11, 2020
    Publication date: October 28, 2021
    Inventors: Friedrich Nolte, Peter Bannas, Kerstin Schütze, William Fumey, Levin Schriewer, Stephan Menzel, Catelijne Stortelers
  • Antigen-binding polypeptides directed against CD38
    Patent number: 10865249
    Abstract: The invention relates to polypeptides specifically binding to CD38 and are therefore suitable for the diagnosis and for the therapeutic and prophylactic treatment of diseases which are characterized by increased CD38 expression. Conjugates and pharmaceutical compositions comprising the polypeptides are disclosed as well. In addition, the invention relates to the use of such polypeptides in methods for the detection of CD38 and/or CD38-expressing cells in a biological sample. A process for the purification and concentration of CD38 and/or CD38-expressing cells in which the antigen-binding polypeptides are used are also described.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: December 15, 2020
    Assignee: University Medical Center Hamburg-Eppendorf
    Inventors: Friedrich Nolte, Peter Bannas, Kerstin Schütze, William Fumey, Levin Schriewer, Stephan Menzel, Catelijne Stortelers
  • ANTIGEN-BINDING POLYPEPTIDES DIRECTED AGAINST CD38
    Publication number: 20190276551
    Abstract: The invention relates to polypeptides specifically binding to CD38 and are therefore suitable for the diagnosis and for the therapeutic and prophylactic treatment of diseases which are characterized by increased CD38 expression. Conjugates and pharmaceutical compositions comprising the polypeptides are disclosed as well. In addition, the invention relates to the use of such polypeptides in methods for the detection of CD38 and/or CD38-expressing cells in a biological sample. A process for the purification and concentration of CD38 and/or CD38-expressing cells in which the antigen-binding polypeptides are used are also described.
    Type: Application
    Filed: November 10, 2016
    Publication date: September 12, 2019
    Applicant: University Medical Center Hamburg-Eppendorf
    Inventors: Friedrich Nolte, Peter Bannas, Kerstin Schütze, William Fumey, Levin Schriewer, Stephan Menzel, Catelijne Stortelers